# Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer

> **NCT06307938** · — · RECRUITING · sponsor: **Helse Nord-Trøndelag HF** · enrollment: 3000 (estimated)

## Conditions studied

- Colorectal Cancer
- Colorectal Adenoma

## Interventions

- **DIAGNOSTIC_TEST:** liquid biopsy

## Key facts

- **NCT ID:** NCT06307938
- **Lead sponsor:** Helse Nord-Trøndelag HF
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-10
- **Primary completion:** 2026-05
- **Final completion:** 2028-05
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2025-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06307938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06307938, "Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT06307938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*